Chronic Kidney Disease

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA guidance · 2007-10-23
Public Statement: Epoetins and the risk of tumour growth progression and thromboembolic events in cancer patients and cardiovascular risks in patients with chronic kidney disease
EMA public statement warning about risks associated with epoetins, including tumor progression, thromboembolic events in cancer patients, an…